California Sen. Kamala Harris and South Bend Mayor Pete Buttigieg are the most formidable of the two dozen Democratic presidential candidates, according to Anthony Scaramucci.
Harris is a “very gifted person ... she has a very good track record to run on,” Scaramucci told Cheddar on Tuesday, noting the she has the ability to rebuild the coalition of voters that elected President Obama.
Better known as the Mooch, Scaramucci also praised Buttigieg’s calculated approach to politics and his sober responses to attacks from President Trump.
Buttigieg has “never once taken President Trump’s bait,” Scaramucci said. “The more successful way to counteract some of the president’s media onslaught and his deft skills at criticizing people is not necessarily go in the mud with him.”
He said that a presidential ticket with Harris and Buttigieg — or Buttigieg and Harris — was a winning strategy. “I’m not a democratic strategist but I would go in that direction,” he said.
Scaramucci is a prominent New York investment banker and the founder of Skybridge Capital. He also served a brief stint as White House Communications Director in 2017, which gave him what he called an “11-day PhD” on Washington culture. His tenure was cut extremely short after he gave an interview to The New Yorker in which he criticized other members of the administration with expletives and derogatory language.
Scaramucci added that Democrats do better in elections with younger nominees — a reality that does not bode well for former Vice President Joe Biden despite his strong polling numbers.
“If they go with Joe Biden … the president will be able to run against his 50 years of sedimentary record inside the Washington establishment,” he said.
Scaramucci also lauded Massachusetts Sen. Elizabeth Warren’s fundraising capabilities and impressive staffing in key states, but predicted that she would lose in a general election against Trump.
“She just has the wrong ideas and the wrong policy solutions for where the American people are right now,” he said.
As the US braces for the what's the follow after the end of the Title 43 pandemic-related restrictions, experts discuss the ramifications with Cheddar News.
New York State Senator John Liu spoke with Cheddar News about Asian-American representation in politics, his bill to make Asian-American history mandatory in schools, and the ongoing hate crimes against his community. State Sen. Liu also discussed the debate over student loan forgiveness and gave his take on artificial intelligence in education.
The Senate Banking Committee held a hearing Thursday on the cannabis bill the Secure and Fair Enforcement (SAFE) Banking — a first step toward what advocates hope will be a full vote on the Senate Floor.
New blood donations rules will allow sexually active gay and bisexual men in monogamous relationships to give in the FDA guidelines ease decades-old restrictions put in place to protect the blood supply from HIV.
During a contentious CNN town hall Wednesday night, former President Donald Trump dug in on his lies about the 2020 election, downplayed the violence on Jan. 6, 2021, and repeatedly insulted the woman whom a civil jury this week found him liable of sexually abusing and defaming.
Criminal defense attorney Tamara Holder joined Cheddar News to break down the charges that New York Republican Congressman George Santos is facing. "When the feds come after you -- and this is for anyone, a politician or not -- they generally have already built their case before they indict you," Holder said, regarding the timeline of Rep. Santos' arrest.
Officials in Missouri's largest city are moving to declare it a sanctuary for people seeking or providing gender-affirming care, defying state officials who are intent on banning it for minors and restricting it for adults.
The Biden administration on Thursday will begin denying asylum to migrants who arrive at the U.S.-Mexico border without first applying online or seeking protection in a country they passed through.
Federal health advisers said Wednesday that a decades-old birth control pill should be sold without a prescription, paving the way for a likely U.S. approval of the first over-the-counter contraceptive medication.
